KCA Annual Conference 2025
14-16 October, Adelaide, SA

Speakers

Angeline Achariya

Dr Angeline Achariya transforms research into real-world impact. With 1200+ innovations commercialised globally, she bridges STEM and market success. Her executive career spans J R Simplot, Mondelez International, Yum! Brands pioneering sustainable food systems across Asia-Pacific markets. As Board Director of Wine Australia, Industry Innovation and Science Australia and Advisory Board member of Australia's Economic Accelerator, she shapes national innovation strategy. Co-founding Monash Food Innovation Centre, the world's first industry collaborative hub, exemplifies her research translation excellence. A Victorian Honour Roll Trailblazer and Fellow of ATSE and AIFST, Angeline delivers STEM-led strategies creating profitable, sustainable growth serving both people and planet.

Kent Anderson

Professor Kent Anderson is an international lawyer specialising in the Asia-Pacific.  He has had senior executive roles at four Australian universities, most recently as Deputy Vice Chancellor at the University of Newcastle. Kent has an eclectic background, having been an academic in Australia, the USA, and Japan; a marketing manager with a US regional airline in Alaska; a commercial lawyer in Hawaii; and senior adviser for higher education to two Australian Ministers of Education. Kent served on a number of boards including National Library of Australia, Ministerial Council for International Education, Higher Education Standards Panel, New Colombo Plan, Canberra Grammar School, Newcastle Australia Institute of Higher Education and President of the Asian Studies Association of Australia.

Anne Bannister

Anne Bannister is the Head of Social & Behavioural Sciences at UniQuest, the commercialisation company of The University of Queensland. She specialises in commercialising UQ’s evidence-based technologies and programs which transform the way global communities tackle mental health and wellbeing, chronic disease, public health, education, and ageing, leveraging technology for enabling sustainable delivery at scale. With previous executive management roles in commercial and non-government organisations, her expertise in building businesses based on commercialising IP was developed in her own start-up. Anne has a Bachelor of Commerce from UQ, is a Chartered Accountant, a Justice of the Peace (QLD Qualified), and is a Graduate member of the Australian Institute of Company Directors.

Martin Bliemel

Associate Professor Martin Bliemel is the Director of Innovation at the Transdisciplinary School at UTS. Martin is an award-winning researcher and educator in innovation and entrepreneurship, with a strong emphasis on complex systems and change. Prior to joining academia, he ran his own startup consulting business, working with startups in chemical manufacturing, wireless hardware, and digital technologies. Martin’s research on startups was central to the design Australia’s Incubator Support Programme and has informed similar policies globally. He has also conducted studies on the emerging nanobiotechnology industry, including analysis of Langer Labs at MIT as a best practice case study.

Evelyn Body

Evelyn is  General Manager IP and AI Governance at Xero a SaaS accounting firm. In this role Evelyn has responsibility for leading and guiding Xero's intellectual Property Strategy.  She has extensive experience in the research sector having led commercialisation and investment teams at Auckland UniServices Ltd and is a former KCA board member. Her career has traversed roles in private practice law and patent firms as well as research organisations, TTOs and start ups as such she is well versed in the needs of various players in the commercialisation ecosystem.  Evelyn has been recognised as an expert in this space, having won Kiwinet's commercialisation professional award as well as being recognised in IAM's IP strategy 300. 

Jayden Castillo

Jayden Castillo is the Chief of Staff and Director of Strategy at Quantum Brilliance, an Australian deep tech startup pioneering room-temperature quantum computers and quantum sensors based on diamond NV technology. With a background in scaling deep tech ventures, Jayden plays a key role in strategic planning, capital raising, and customer development, helping bridge the gap between cutting-edge science and commercial outcomes. He is passionate about building autonomous, high-impact teams and driving innovation at the intersection of quantum technology, semiconductors, and advanced manufacturing

Will Charles RTTP

Will Charles has been Executive Director Investment since 2005. In the last six years alone UniServices has started, supported and invested in 43 technology-based companies that have raised nearly $1 billion million in venture and seed funding for these companies. In 2016 he founded and manages the University of Auckland Inventors Fund, a $40m evergreen fund dedicated to start-ups generated by staff and students at the University of Auckland.

Larisa Chisholm

An accomplished life sciences executive, Larisa brings cross-functional expertise from ASX, NASDAQ, academia, not for profit and startup companies.   Larisa spent 14 years at ASX listed Immutep (formerly Prima BioMed) and excels in strategically aligning vaccine research, clinical trials, manufacturing, and commercialisation.An active contributor to advancing education, she supports aspiring students, scientists, and women entrepreneurs through her involvement with the Life Science Springboard program, RMIT Biomedical Science Industry Advisory Committee and Central Pharmacy Logistics.Bachelor of Science (Honours), MBA La Trobe, Australian Institute of Company Directors.

Dave Christensen RTTP

Dave is an experienced manager with responsibility for the University of Otago's commercialisation company - Otago Innovation Ltd. He joined Otago Innovation in 2007 as a commercialisation manager, and subsequently held senior commercialisation manager and GM roles in the organisation, before taking up the reigns as CEO in 2018. Dave has a wealth of experience in assessing, project managing and concluding deals based off of academic research. In addition to managing the company’s day to day activities, Dave has been and continues to be involved in a number of investment committees such as Return on Science’s Biotech & Pharma &Otago Momentum, as well as the Brandon BioCatalyst investment review committee. Dave also serves on various start-up company boards.As the University of Otago's commercialisation company, Otago Innovation is responsible for the identification, protection and transfer of intellectual property generated by academic staff at the University of Otago to newly formed spinout companies or established industry.

Emma Coath

Emma Coath is a highly regarded business leader in the Australian agrifood sector and is passionate about identifying, and supporting the development of, local solutions to global challenges related to sustainability such as food security. She leverages her extensive network and understanding of the agrifood ecosystem to connect entrepreneurs and researchers with investment and market opportunities, and to facilitate cross-sector collaboration and knowledge exchange. Emma has been awarded multiple scholarships and honors for her academic excellence and business innovation and is currently Chair of Rocket Seeder.

Fairlie Delbridge

Fairlie is a 2024 Harvard Advanced Leadership Initiative Fellow, Co-Founder of LEKI Electric Motorcycles, Modmade Tiny Homes and an Investor, Advisor and Mentor to a portfolio of start ups in both Australia and the US.She is a former Chair of the Real Estate Institute of South Australia, she has held board roles at the Adelaide Economic Development Agency, Junction Australia and Unity Housing.She is also a graduate Fellow of the Vincent Fairfax Fellowship in Ethics and Leadership, was an inaugural Commissioner on the State Planning Commission and past Deputy Chair of Scotch Colleges Council of Governors.Her early career transversed organisations such as Coca-Cola and Citibank and she was also an owner/director of numerous McDonald’s franchises in Australia, she is also a former General Manager of Strategy and Innovation at Renewal SA She is a Fellow of the Australian Institute of Company Directors, a life long entrepreneur, current founder, angel investor, and a tireless advocate for South Australia and the pursuit of Innovation.  She has four adult children, a naughty Beagalier named Bonnie, loves cycling, skiing, swimming, yoga and solving the big, hairy, audacious problems of the times with the next generation of leaders.

Anne-Maree Dowd

Dr. Anne-Maree Dowd, Principal Consultant at Tractuum, is a highly regarded expert in corporate strategy, portfolio and impact management, enterprise performance, and evaluation. She holds a PhD in Organisational Behaviour and has amassed 25 years of experience in scientific research and knowledge mobilisation. Recently, Dr. Dowd co-edited the pivotal book "Cornerstones of Impact Management," collaborating with leading global contributors to advance thought leadership in the field of impact.

Andrew Dunbar

Andrew is the Executive Director, Industry, Innovation and Small Business Group (IISB) in the Department of State Development, South Australian Government. In this role Andrew is responsible for developing and supporting the state’s innovation system and developing industry policy in partnership with other parts of government, research organisations, industry and business. The IISB Group is focused on supporting sustainable economic growth by increasing South Australia’s global standing in science and research, encouraging commercialisation of research through industry, research and government collaboration, and supporting entrepreneurs, start-ups and small business and attracting early stage and venture capital. Previous roles in the South Australian Government have included the Chief Operating Officer, Office of the South Australian Chief Entrepreneur and prior to this role, Director of the Office of Science, Technology and Research within the Department. Andrew has a PhD in molecular biology/biochemistry from Flinders University, and is a Andrew is a Graduate Member of the Australian Institute of Company Directors (AICD).

Francois Duvenage

Francois Duvenage is a technology transfer leader and innovation strategist with deep expertise commercialising early-stage research and forging global industry partnerships. Francois has a law degree and MBA in strategy and technology management. As Director of Commercialisation and board member of Innovation & Commercial Partners, at the University of Adelaide, he leads initiatives that turn research into real-world impact—driving spinouts, licensing deals, and investor engagement. Earlier, he was General Manager at South Africa’s Council for Scientific and Industrial Research, where he led the consulting and commercialisation business area. Back in 2001, he started his own law firm which was acquired and then co-founded a consultancy firm specialising in merger & acquisitions.

Dom English

Dom English is the Head of the Secretariat for the Strategic Examination of Research & Development, based in the Department of Industry, Science and Resources. He has worked in the Australian Public Service for more than 30 years, with experience in central agencies and the Education and Industry portfolios.

Tennille Eyre

Tennille Eyre is the Program Director of CSIRO’s ON Program, Australia’s national accelerator for publicly funded research. A people-first leader with a background in design, Tennille focuses on building inclusive programs and ecosystems that support researchers to explore pathways to impact. Her work spans capability-building, national collaboration and enabling connections across the research and innovation landscape. She is passionate about inclusive innovation and creating the conditions where people, purpose and possibility come together to drive meaningful change.

Cathy Foley

Dr Cathy Foley AO PSM served as Australia’s Chief Scientist until December 2024, following a distinguished career at CSIRO, including as Chief Scientist. A world-renowned physicist, she led pioneering research in superconductors and sensors, culminating in the LANDTEM mineral exploration system. As Chief Scientist, she advanced national quantum and research strategies. Her leadership and advocacy for women in STEM earned her many accolades, including Fellowship in the Australian Academy of Science and an Order of Australia. She is also a Fellow of ATSE and the Australian Institute of Physics, and remains a powerful advocate for research translation, open access to research literature and scientific excellence.

George Freney

George is an experienced entrepreneur passionate and curious about uncoveringand validating ideas that address intractable problems relating to protecting theplanet, freedom, and people’s wellness. He was and is involved with manytechnology-centric businesses as an investor, advisor, founder, director andexecutive. In 2007, he helped found conTgo, a market-leading mobile traveltechnology platform, was sold to Concur in 2013. In 2012 he co-founded booodl tosolve a complex problem for physical retail businesses. He led the company fromthe initial idea through 5 rounds of fundraising, securing strategic customers andpartnerships, multiple strategy and product pivots and the decision to stoppursuing the mission. George is a founding partner at 11point2 and co-founder ofSpace Machines Company. He was previously a Member of the Flinders UniversityGoverning Council, a board member of the RAA of SA Inc and an inauguralmember of the South Australian Entrepreneurship Advisory Board.

Sharmila Gamlath

Sharmila Gamlath is an Assistant Director within the Research Program Delivery Branch in the Programs and Student Experience Division at the Australian Government Department of Education. Sharmila is an economist cum statistician by training with a PhD in macroeconomic modelling who entered the public service after working as a teacher and academic in Australia and overseas for many years. Her current role at the Department primarily involves research and analysis to inform and evaluate the Australian Government’s Research Translation and Commercialisation Agenda and analysis of the characteristics of Australia’s researcher workforce.

John Grace AO RTTP

John is an Independent Director on KCA’s board, since joining in 2018 as the representative of UniSA Ventures. He is the Treasurer of KCA and is the Chair of the SCOPR Committee. He has a Bachelor of Science degree from UNSW, a Fellow of the Academy of Technological Sciences and Engineering and a Fellow of the Institute of Company Directors.  John has worked in the biotechnology research commercialisation space for over 50 years.  He was the Chief Executive Officer for 11 years of AMRAD a listed company commercialising medical research technology. He has been a member of many government committees and private company boards. His award as an Officer of the Order of Australia in 2018 was for his contribution to biotechnology research and its commercialisation. 

D'vorah Graeser

Dr. D’vorah Graeser is a scientist, entrepreneur, and AI strategist with a lifelong passion for technology and innovation. With a PhD in Pharmacology from the University of Michigan and a BA in Biochemistry from Harvard, she began her career programming for the Human Genome Project and went on to found multiple companies, including RocketSmart.io: an AI-powered platform supporting innovation ecosystems. A US Patent Agent and ForHumanity Fellow, she is also the author of The AI Process Playbook for Business and a TEDx speaker. Known for combining deep technical knowledge with business insight, D’vorah brings a unique blend of scientific rigor, strategic foresight, and human-centered thinking to the future of AI and innovation.

Ellen Gorissen

Ellen has more than 25 years’ experience in strategy, business development, technology commercialisation and venture capital. She started her career as a chemical engineer in the resources sector before moving into investment banking, venture capital and technology commercialisation. Her passion is bringing new technologies to market and working with startups and new venturesEllen is the Lead Priority Manager at Australia’s Economic Accelerator, a $1.6 billion program taking a new approach to commercialising academic research from Australia’s Universities. She has been intensely involved in commercialising deep tech in her role as the CEO of Jovian Tech, a startup commercialising hydrogen sensors and, as the General Manager, Commercial for HB11 Energy, Australia’s only nuclear fusion company. Ellen was Investment Director at IP Group Australia, the Australian subsidiary of IP Group plc, a global technology investment and commercialisation company listed on the London Stock Exchange. In this role she led investments into IP based start-ups, often originating from Universities or Research Institutions. Prior to joining IP Group, Ellen led the Commercialisation Function at the CSIRO and was responsible for complex licensing, spinouts and equity portfolio across all technology areas. In this role she led a team of 7 professionals to identify technologies with commercial potential and accelerate their development to commercialise. Before CSIRO, Ellen was Chief Operating Officer at CeramiSphere, a spin out from the Australian Nuclear Science and Technology Organisation (ANSTO).Ellen brings a unique understanding and skill set to the emerging technology space having worked across all technology sectors from Agtech and Biotech to Space tech, AI, Quantum and 3D printing and Cleantech. She has a strong interest in decarbonisation, sustainability and impact investing. Her diverse experience spans domestic and international markets, global corporations, universities, government and start-ups. She has raised tens of millions of dollars in early-stage capital and has served on the boards of multiple spin outs and early-stage growth companies. She also brings unparalleled networks and relationships within the Australian & NZ research sector, start-up communities, domestic and international venture capital and innovation ecosystems.

Lusia Guthrie

With a 45-year career in the pharmaceutical and bioscience industries, Lusia Guthrie is a Company Director who has maintained her passion for innovation, leadership and entrepreneurship. She is a company founder and experienced former CEO. Lusia is a technology developer with a proven track record in translating technologies into commercial outcomes. She is accomplished at defining strategy, raising capital, building teams, fostering cultural change, and maintaining strong internal and external relationships. She has worked and collaborated globally and around Australia.Lusia is presently actively engaged with industry, government, and academia through various board, advisory and mentoring roles, including: Chair of Innovation & Commercial Partners (ICP), the equity holding company of the University of Adelaide; and Chair of Neo-Bionica, a Melbourne-based company serving the global neurotechnology market.Lusia embraces change and life-long learning, giving freely of her time to mentor researchers and emerging entrepreneurs. She is dedicated to advancing the Australian medtech sector and fostering a culture of innovation, collaboration, and excellence. 

Judy Halliday

Dr Judy Halliday is the Director, Innovation and Entrepreneurship in the Department for State Development. In this role, she is responsible for delivering on the Government’s commitment to grow South Australia’s capacity for competitive global excellence in research, translation and commercialisation and to grow entrepreneurship and supporting start-up and scale up business in South Australia.Judy has more than 25 years of executive and management experience in entrepreneurship and innovation as an inventor, founder, investor, academic and industry professional in the private and public sectors. She has published in peerreviewed academic journals and has been successful across many competitive grant programs as both an academic researcher and as an industry partner. She is an inventor on granted patents and has been involved in raising millions of dollars for startup companies. She has negotiated complex multi-million-dollar licensing transactions and collaboration agreements in the development of early-stagetechnologies. 

Michael Harvey

Dr Michael Harvey is the Director of New Ventures at Quantum Australia - Australia's centre for quantum growth - where he operates a national program to stimulate building new quantum businesses and new quantum products in Australia.Michael trained in law and science, and was awarded a PhD in physics from the University of Queensland. Before joining Quantum Australia Michael was the Translational Research Manager for the ARC Centre of Excellence for Engineered Quantum Systems (EQUS) where he built a program with a budget of $3M and created 21 commercial outcomes, including 9 quantum technology startups, with projects bringing in ~$96M in commercial and grant funding. He established similar programs at the Centre of Excellence for Future Low-Energy Electronics Technologies (FLEET) and the Centre of Excellence for Quantum Biotechnology (QUBIC). Prior to joining EQUS Michael was Chief Technology Officer at XeroCoat Inc and Brisbane Materials Technology Pty LtdMichael has lived and worked in Australia, Silicon Valley, Europe, China, & Taiwan, he is a technical advisor to some Australian VC funds, and has co-founded several deep-tech startups in Australia and the USA so far having raised >$60M in venture investment for these businesses. He is an advisor or non-executive director of multiple Australian startups commercialising hydrogen process sensors, power semiconductor devices, quantum data security, low-energy edge AI, superconducting devices, and novel battery chemistries.

Alastair Hick

Dr Alastair Hick is Chief Commercialisation Officer at Monash University, overseeing a successful IP commercialisation program, and developing an ecosystem approach to innovation. He has made exceptional contributions to the field of research commercialisation and innovation throughout a career that spans more than 25 years, marked by significant achievements on an international scale. Formerly Chair of Knowledge Commercialisation Australasia from 2015-2018, and on the Board from 2009-2018, Dr Hick became a Life Member in 2020. In 2023 named Technology Transfer Professional of the Year. He has a PhD in Chemical Ecology, an MBA from Cambridge, and is a Director of multiple Monash spinouts. 

Olga Hogan

Olga is a Chartered accountant with a PhD in Electrochemistry and international experience spanning the full spectrum of corporate M&A, venture capital, private equity, and university research commercialisation.As a Senior Investment Director at Breakthrough Victora, Olga manages the $100 million University Innovation Platform – a Pre-Seed Co-investment partnership with universities in Victoria. The platform helps drive the commercialisation of university research through investments in startups and spinouts, as well as co-funding operational support.

Rock Hudson

David is passionate about the contribution and future of agbiotech to Australian and global agriculture. During a 23 year career with Monsanto, David was actively involved in the development and adoption of conservation tillage by Australian farmers. Since 1996 David has been actively involved in the introduction of Australia’s first agbiotech crops, Ingard® Cotton, Roundup Ready® canola and most recently Super High Oleic Safflower. Since establishing his consulting firm, SGA Solutions in 2006, followed by PTM Solutions in 2014, David has provided consulting services to Australian and international private and public sector clients in the development and implementation of pathway to market strategies for innovative technologies applicable to the grains, horticulture, livestock, forage, forestry and seafood industries. 

Kimberly Hunter

Kimberley is a Nyikina woman from the Martuwarra Fitzroy River in the West Kimberley region of Western Australia. Born and raised on Kaurna Yerta in Adelaide, South Australia, she holds a Bachelor of Applied Science (Occupational Therapy) and a Graduate Certificate in Public Health.Kimberley is the Design and Engagement Co-lead at the Wiyi Yani U Thangani Institute for First Nations Gender Justice, housed at the Australian National University. The Institute builds on the landmark Wiyi Yani U Thangani (Women’s Voices) Project, and is Australia's first independent Institute dedicated to advancing the rights, knowledges, and aspirations of First Nations women, girls and gender-diverse peoples as powerful drivers of systemic change.

Mark Hutchinson

Professor Mark Hutchinson is Director of the Institute for Photonics and Advanced Sensing at the University of Adelaide. A leader in neuroimmunopharmacology and biophotonics,  his research on glial cells has transformed understanding of pain, addiction, and neurological disorders. His research has led to transformative clinical applications, from laboratory concepts to bedside treatments. Mark’s impact extends beyond academic achievements, fostering strong industry partnerships and commercial translations. He holds key national roles, including on the Prime Minister’s National Science and Technology Council, and on the Australia's Economic Accelerator board. 

Seth Jones

Dr Seth Jones is WEHI’s Entrepreneurship Lead, where he played a pivotal role in structuring the IonOpticks deal and led the spinout of Research Code Pty Ltd. With 30 years in technology transfer, he has shaped commercialisation strategy at WEHI and JCU, raised capital for spinouts, and engaged with government on translation policy. He has delivered over $100M in outcomes across biotech, agriculture, and clean energy. Seth has served on eight spinout boards, including as Chair of NutriV Pty Ltd, led complex licensing deals, and coordinated JCU’s Innovation Strategy. He holds a PhD in Biochemistry and is a graduate of the AICD.

Shane Kilcullen

Shane Kilcullen brings a diverse career spanning start-ups, multinationals, and government sectors, with the past seven years focused on university technology transfer at the University of Melbourne. While trained as a mechanical engineer, Shane now navigates an extensive range of technologies across multiple disciplines. He is particularly passionate about artificial intelligence and its potential to enhance professional productivity. Through his leadership of KCA's AI Special Interest Group over the past year, Shane has developed deep insights into the unique challenges and opportunities facing the commercialisation community. This understanding has informed his co-design of this workshop, specifically tailored to help technology transfer professionals maximise AI's impact in their daily practice.

Jonathan Lacey

Jonathan Lacey is co-founder and partner at Cruxes Innovation, which exists to help universities, research organisations, and innovative companies unlock the huge potential of Australian researchers and innovators to make a positive difference in the world. We believe the best way to do this is to work alongside researchers and innovators to build partnerships between research, industry, community groups, and government to solve real-world problems.  Jonathan started his career as a physical science and engineering researcher at the University of Melbourne. He spent 10 years in Silicon Valley where he became fascinated by helping other researchers make a difference in the world with their ideas, in large companies and research spinouts.  He returned to Australia to lead a spinout based on Monash University research.  It raised $10M but failed.  The focus of his career since then has been putting the lessons he learned here to work in creating impact with research.

Cathryn Lee

Cathryn Lee is a Commercialisation Manager at the University of Adelaide, with specialist portfolio skills in the Agricultural and Life Sciences area.  With a PhD in Materials Science and Engineering, Cathryn trained as a Wool Technician and has worked in commercial and RDC roles prior to joining the University in 2021. Cathryn supports researchers with IP and Commercial terms in research project contracts, as well as in taking research outputs to market through licensing and incubator programs.

Andre Luiten

Andre is MD/CTO of QuantX Labs as well as Chief Innovator of the Institute for Photonics and Advanced Sensing (IPAS) and Chair of Experimental Physics at the University of Adelaide. Andre was previously Director of IPAS for over 10 years.Andre is a fellow of the Australian Academy of Technological Sciences & Engineering and the Australian Institute of Physics and has raised over $50M for research. He obtained his PhD in Physics from the University of Western Australia in 1997, for which he was awarded the AIP Bragg Gold Medal. Andre was the joint inaugural winner of the WA Premier’s Prize for Early Career Achievement in Science. In 2013, Andre came to the University of Adelaide to take up a South Australian Research Fellowship from the SA Premier’s Department. In 2016, Andre co-founded a company, QuantX Labs, to exploit his leading-edge research. This company has been profitable from its foundation and now has 42 staff. 

Sanjay Mazumdar

Dr Sanjay Mazumdar is a proven chief executive and board director with over 30 years of experience in the defence, national security and ICT sectors.Sanjay is the Executive Director (Chief Executive) of the Defence Trailblazer, a $200+ million enterprise comprising 100+ industry partners, the University of Adelaide and UNSW, with funding from the Australian Government through the Trailblazer Universities Program.Sanjay’s previous roles include: • Defence and Technology Partner at KPMG Australia• CEO, D2D CRC Ltd • CEO, Defence Systems Innovation Centre• Head of Engineering Operations, BAE Systems Australia• Operations Manager, Motorola• Engineer, DSTO (now DSTG).

Andrew McLean

Dr. Andrew McLean is following his passion for working with inventors to build businesses solving generational human & global challenges. He has a passion for supporting entrepreneurs on the courageous journey of company-building and its source of growth & development.As part of the founding team at Oxford Science Enterprises he led investments into DJS Antibodies (acquired by Abbvie) mirobio (Acquired by Gilead), Vaccitech (inventor of the Oxford-AZ covid vaccine), Pepgen and hired the founding team of Base Genomics. He studied medicine at UWA and philosophy, politics, and economics at Oxford.Andrew has a passion for prime numbers, running and learning new languages. His current project is Yolngu Matha (an east Arnhem language)

Rob McInnes

Rob originally trained as a protein chemist, but has been an intellectual property lawyer for more than 30 years, specialising in IP transactions.  His work mainly involves planning, negotiating and structuring licence agreements and R&D contracts, and conducting due diligence on new technology ventures for investors.Currently Rob is shifting his focus away from legal work and towards angel investing, training, mentoring and advisory committee roles - but he remains active in assisting spinout teams and has helped around 20 spinouts reach agreed terms with their institutions in the past 5 years.

Peter Murphy

Peter is Deputy Vice Chancellor Research & Enterprise at UniSA, and new Pro Vice Chancellor Research Translation at Adelaide University, reflecting his experience in identifying, driving and supporting business development opportunities and translating research discoveries into real-world applications. Peter’s own research encompasses the engineering of surfaces and extends to applications in the optical, automotive, aerospace, defence, mining and renewable energy industry sectors. He has won more than $25 million of research grant funding and was awarded the 2016 ATSE Clunies Ross Award for Innovation for his work in the development of the world’s first plastic, external automotive rear-view mirror.

David McKeague

David McKeague MBA, Beng (Elec) is a serial venture builder with over 30 years experience in building and commercialising research. Bridging the gap!David has worked in large scale engineering projects including aluminium smelter energy systems both for Boyne Smelters and also Portland Smelter second expansion in automation and plant energy management systems. David has also headed the Systems Engineering for ISCMMS on the Collins Class submarine propulsion, habitability and battery management, F-111 Mission Simulator and has led the Business Development for Australian military C4ISR systems.In addition, David has personally been Venture Building numerous research lab spinouts both at wireless semiconductor (acquired by AMD), embedded AI on the phone funded by Intel Capital, Warner Bros, venture funded voice Gen AI startup and energy storage.

Joe Neale

Joe Neale has nearly twenty years’ experience across venture capital, operations, and entrepreneurship in London and Zurich, driven by a passion for connecting venture capital, academic innovation, and regional development.He is relocating to Adelaide with his young Australian family and is eager to engage with the Australian innovation ecosystem. Joe currently supports Adelaide’s Eastend Ventures as a Venture Partner, while also advising universities, corporates, family offices, and venture funds on building venture-driven innovation ecosystems through his advisory firm, Techstone.Most recently, Joe was a Partner at VI Partners, ETH Zurich’s US$110m venture fund, where he developed the firm’s “digitalisation of the corporation” investment strategy. This flywheel model connected university spin-outs with both funding and large corporations seeking innovation solutions. During his tenure, he led four investments in AI, fintech, deep tech, and SaaS, including a potential future unicorn, Unique. He also served as a member of ETH Zurich’s Tech Transfer “Value Creation Strategy” strategy group. Previously, Joe was the founding Principal of m8 Capital, a US$50m London-based venture fund focused on mobile technology. The portfolio delivered multiple exits, including a seed-to-IPO journey (Fuller KK) and a seed-to-unicorn success (Noom), which achieved a 1,200x valuation increase. Collectively, portfolio companies went on to raise more than US$1b in follow-on capital from leading investors including Sequoia, Silver Lake, Founders Fund, KPCB, Accel KKR, and Samsung Ventures.

Ann Nolan

An experienced innovation leader and former investor backed deep technology entrepreneur, as well as social venture founder, Ann brings over 20 years’ expertise in strategy, early-stage business creation, partnership development and brand building across not-for-profits, startups, academia and private enterprise. With a proven track record in translating technology offerings into commercial outcomes, Ann is the Commercialisation and Social Innovation Manager at Monash University. Her extensive experience sees her leading research commercialisation from Humanities, Arts and Social Science and helping guide development of an ecosystem approach to social innovation more broadly across the university. She has a Bachelor of Arts (Psychology) and Masters of Community Development from University College Galway, Ireland and an Advanced Dip. in Screenwriting (Film, TV & Digital Media) from RMIT.

Melissa Nugent

Melissa Nugent is Chair of the KCA Qld Chapter and a Senior Manager in QUT’s research partnerships and technology transfer office, specializing in agriculture and bioeconomy initiatives. Over her career Mel has led stakeholder engagement portfolios across Higher Education, Government, and NFP sectors – driving innovation and impact through collaboration.Prior to her current role at QUT, she was Director Business Development at ARM Hub, a national not-for-profit advancing manufacturing in Australia through AI and robotics innovation and adoption. Mel is a strong advocate for the role of technology transfer professionals in navigating the challenging path from tech innovation to adoption in important sectors including agriculture. 

Andrea Perry-Petersen

Andrea Perry-Petersen is Head of Business and Social Innovation at Griffith Enterprise, where she leads initiatives that support social science researchers across the Arts, Education, Law, and Business disciplines. Her work focuses on enhancing engagement, commercialisation, and knowledge translation to drive meaningful, real-world impact.A Churchill Fellow, Andrea investigated global innovations in access to justice and created the podcast Reimagining Justice, which explored transformative approaches to legal and social systems. Her previous academic and research roles centred on the ethical dimensions of technology adoption and workplace transformation.Andrea brings a multidisciplinary background to her role, underpinned by her legal training and complemented by expertise in governance, human rights, and strategic partnerships. She brings a unique perspective on innovation and systems change as a result of roles across academia, government, not-for-profit organisations and industry.

Erin Rayment RTTP

Dr Erin Rayment is Vice-President (Business Development) at QUT and has over 15 years’ experience in academic research, industry engagement and commercialisation. She also holds leadership roles in organisations that support the development and growth of the Australian innovation ecosystem, including as Director at the Translational Research Institute Australia, Director at Knowledge Commercialisation Australasia, Chairperson of QUT Bluebox, and as a Reef Restoration and Adaptation Program board member. An interdisciplinary biologist with expertise in regenerative medicine, cell therapy and bioprocessing, Erin is also a Superstar of STEM, a program that aims to increase the visibility and diversity of women in science, technology, engineering and mathematics. Her mission is to foster collaboration, innovation, and impact across disciplines and sectors.

Carlie Rogers

Carlie Rogers is the Lead for Technology Transfer for the Humanities, Arts and Social Sciences (HASS) at the University of Melbourne, where she champions the commercialisation of research with a strong social purpose. With a background in business development, trade and investment across public and private sectors, Carlie brings a strategic and commercially focused approach to translating HASS research into real-world outcomes. She has been instrumental in helping shape the University’s approach to social ventures and is an advocate for the role of HASS in building more inclusive, purpose-driven innovation ecosystems.

John Rock

John Rock is CEO of Out The Back Ventures, where he partners with leading researchers to uncover high-potential ideas. Known for deep due diligence and sharp commercial instincts, he builds diverse, collaborative teams to turn early-stage research into impactful ventures. With years of experience bridging academia and industry, John specialises in forging partnerships that unlock value and drive real-world outcomes.

Carmela Sergi

Carmela is the CEO and Managing Director of the Care Economy CRCShe is committed to improving health and care through collaboration, knowledge translation and industry uptake of research outcomes. An accomplished senior executive and intellectual property attorney Carmela has worked over 30 years across pharmaceutical, medical technology, aged care and health service sectors. Experienced in leading large and complex research & industry collaborations Carmela brings a focus on commercialisation and translational impact. Carmela has proven experience in developing partnerships at local, national and international levels working with diverse stakeholders such as governments, universities, health services, consumer organisations and business.

Emerald Scofield

Emerald is an Associate at Main Sequence Ventures, where she backs deep-tech founders and helps scale groundbreaking companies with the potential to change the world.With six years in deep-tech investing, Emerald focuses on Feeding 10 Billion People, Decarbonising the Planet, and Humanity Scale Healthcare. She is deeply involved in early-stage investment and company building, backing founders to turn cutting-edge science into real-world impact while also supporting companies as they scale.Before joining Main Sequence, she invested in deep tech at a New Zealand-based fund, working across similar sectors. Emerald has also been on the startup side—working to scale a medtech company and leading an early-stage climate tech startup—experiences that built a strong sense of founder empathy and an appreciation for the highs and lows of building a company.

Elaine Stead

Elaine Stead is a member of the investment team at Main Sequence, with a focus on the “Humanity Scale Healthcare” challenge. With a background spanning science, entrepreneurship, and venture capital, she's known for her enduring roles in innovation and has an investment track record that extends to over 80 startups across Australia, the United States and Southeast Asia.  Previously, Elaine served as the Director of New Ventures and Entrepreneurship at the Australian National University (ANU), leading the startup and equity investment strategy of knowledge translation. She has also been a founder of venture businesses, including Blue Sky VC, Human VC and Tribe Global Ventures.Elaine has advised state governments on innovation policy, directed innovation initiatives, and served on boards in Australia and the US. She's coached startup founders nationwide and contributed to a variety of publications. In all avenues, Elaine prioritises human-centricity, emphasising authentic connections, vulnerability, and compassion. She advocates for values-driven innovation and a desire to make better that which can be.Elaine holds a Ph.D. in Biochemistry (Stem Cell Biology) and a B.Sc.in Biochemistry and Microbiology, both from the University of Adelaide.

Elise Stephenson

Dr Elise Stephenson is an award-winning researcher, strategist, and entrepreneur whose work sits at the intersection of innovation and equality. As Deputy Director of the Global Institute for Women's Leadership at the Australian National University, Elise leads groundbreaking research and has advised government, industry, and civil society on how to build more inclusive and globally competitive institutions. She brings a unique blend of academic rigour and entrepreneurial insight to the challenge of translating knowledge into impact. Elise will share her expertise on how to unlock the full potential of research and innovation ecosystems—by embedding equity, embracing complexity, and designing for the future.

Jason Strong

Jason Strong is an Australian agriculture industry and business leader.  He has 35 years’ red meat and livestock experience from the farm through to the consumer, in both Australian and international markets. This experience includes developing and managing start ups through to large companies, managing commercial operations and providing leadership and strategic direction to R&D and marketing programs.  Jason has been Managing Director of Meat & Livestock Australia, CEO, Smithfield Cattle Company, Managing Director of Australian Agricultural Company, MLA’s regional manager in Europe and Russia, International Business Development for Pfizer Animal Genetics (now Zoetis), past Chair of the Australian Beef Industry Foundation.  He also has experience in Agri Political and representative organisations. 

Kate Taylor RTTP

Kate Taylor is Executive Director of Industry Engagement at Queensland University of Technology (QUT), where she leads efforts to drive strategic research partnerships, foster innovation, and commercialise QUT’s intellectual property. With over 13 years of experience in technology transfer and business development, Kate’s experience spans diverse sectors including health, agriculture, defence, education, and creative industries, all aimed at delivering impactful, real-world outcomes. Kate is a Registered Technology Transfer Professional and holds a Bachelor of Biotechnology (First Class Honours) from the University of Queensland. She is also a graduate of the Australian Institute of Company Directors. In addition to her role at QUT, Kate serves on the board of the Queensland Social Enterprise Council and chairs the Queensland Network Chapter of Knowledge Commercialisation Australasia. Recognised as an AgriFutures Future Young Leader in 2019, Kate is committed to fostering collaboration and entrepreneurship across sectors. 

Steve Trench

Steve Trench, Santos Executive Vice President, Operations and Technical Services Corporate Function. He is responsible for global operations and technical management systems, capabilities and performance oversight across, health, safety and environment, production operations, projects and supply chain and innovation. Santos operates across Australia, PNG, Timor Leste and North America. Steve has 25 years of global experience in the oil and gas industry. Before joining Santos, he spent 22 years at Woodside Energy where he held technical and operational leadership roles, including leadership of the North West Shelf Project’s Karratha LNG asset. Steve also served in strategy, business management and governance roles, including as Vice President of Strategy, Planning and Analysis.

Ingmar Wahlqvist

Ingmar leads Monash University's New Ventures and Investments team. With a background as a medical doctor and an MBA, he brings over 20 years of experience in venture capital, strategy consulting, early-stage business creation and management, and pharmaceutical industry roles. His extensive expertise focuses on commercialisation and venture capital investment in biomedical and healthcare companies.

Thank you to our Sponsors

Platinum & Merchandise Sponsor




Dinner & Award Night Sponsor

 


Coffee Cart Sponsor



Gold Sponsor

Welcome Reception Sponsor


Bronze Sponsor



Silver Sponsor







Member Organisation Sponsor







Contact:

KCA Professional Conference Organiser
P: 02 9431 8600
E: conference@techtransfer.org.au

© Copyright 2023 KCA Annual Conference